R
Richard Danila
Researcher at Centers for Disease Control and Prevention
Publications - 73
Citations - 7503
Richard Danila is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Population & Public health. The author has an hindex of 29, co-authored 70 publications receiving 7099 citations. Previous affiliations of Richard Danila include University of Minnesota.
Papers
More filters
Journal ArticleDOI
Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection.
Timothy S. Naimi,Kathleen H. LeDell,Kathryn Como-Sabetti,Stephanie M. Borchardt,David Boxrud,Jerome Etienne,Susan K. Johnson,François Vandenesch,Scott K. Fridkin,Carol O'Boyle,Richard Danila,Ruth Lynfield +11 more
TL;DR: It is suggested that most community-associated MRSA strains did not originate in health care settings, and that their microbiological features may have contributed to their emergence in the community.
Journal ArticleDOI
Group B Streptococcal Disease in the Era of Intrapartum Antibiotic Prophylaxis
Stephanie J. Schrag,Sara Zywicki,Monica M. Farley,Arthur Reingold,Lee H. Harrison,Lewis B. Lefkowitz,James L. Hadler,Richard Danila,Paul R. Cieslak,Anne Schuchat +9 more
TL;DR: Over a six-year period, there has been a substantial decline in the incidence of group B streptococcal disease in newborns, including a major reduction in the excess incidence of these infections in black infants.
Journal ArticleDOI
Active bacterial core surveillance of the emerging infections program network.
Anne Schuchat,Hilger T,Elizabeth R. Zell,Monica M. Farley,Arthur Reingold,Lee H. Harrison,Lewis Lefkowitz,Richard Danila,Karen Stefonek,Nancy L. Barrett,D. Morse,Robert W. Pinner +11 more
TL;DR: In 1998, early-onset group B streptococcal disease had declined by 65% over the previous 6 years, and 25% of invasive pneumococcal infections in ABCs areas were not susceptible to penicillin, and 13.3% were not susceptibility to three classes of antibiotics.
Journal ArticleDOI
Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine.
Catherine Lexau,Ruth Lynfield,Richard Danila,Tamara Pilishvili,Richard R. Facklam,Monica M. Farley,Lee H. Harrison,William Schaffner,Arthur Reingold,Nancy M. Bennett,James L. Hadler,Paul R. Cieslak,Cynthia G. Whitney +12 more
TL;DR: The findings indicate that use of conjugate vaccine in children has substantially benefited older adults, and persons with certain comorbid conditions may benefit less than healthier persons from the indirect effects of the new vaccine.
Journal ArticleDOI
The Changing Epidemiology of Meningococcal Disease in the United States, 1992–1996
Nancy E. Rosenstein,Bradley A. Perkins,David S. Stephens,Lewis Lefkowitz,Matthew L. Cartter,Richard Danila,Paul R. Cieslak,Kathleen A. Shutt,Tanja Popovic,Anne Schuchat,Lee H. Harrison,Arthur Reingold +11 more
TL;DR: The most commonly expressed serosubtype was P1.15; 68% of isolates expressed 1 of the 6 most common sero-subtypes as discussed by the authors, indicating that serogroup Y was more likely to cause cases of meningococcal disease in older age groups.